DURHAM | Jotup

BioCryst to Report First Quarter 2024 Financial Results on May 6

Retrieved on:

Monday, April 22, 2024

RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024.

Key Points:

RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024.
BioCryst management will host a conference call and webcast at 8:30 a.m.
ET that day to discuss the financial results and provide a corporate update.
A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com .

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency

Retrieved on:

Wednesday, April 17, 2024

BioCryst Pharmaceuticals, LATAM, Hereditary angioedema, Pint, Patient, ANVISA, Marketing, HAE, Brazilian Health Regulatory Agency, Pharmaceutical industry

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older.

Key Points:

RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older.
“We are excited to announce that ORLADEYO is now approved in the region’s largest market, following the positive regulatory decisions we received in Chile and Argentina last year.
We look forward to working with our partner, Pint Pharma, to make ORLADEYO available in Brazil and across LATAM,” said Charlie Gayer, chief commercial officer of BioCryst.
BioCryst has an exclusive collaboration with Pint Pharma GmbH to register and promote ORLADEYO in the pan-Latin America region.

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on:

Tuesday, April 16, 2024

Compensated emancipation, Patient, ONC201, Employment

The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4).

Key Points:

The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4).
The stock options have an exercise price per share equal to Chimerix’s closing trading price as of the grant date.
The stock options are subject to the terms of Chimerix’s 2013 Equity Incentive Plan but were granted outside of the 2013 Equity Incentive Plan.
Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases.

Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call

Retrieved on:

Thursday, April 11, 2024

DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.

Key Points:

DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session.
To participate in the earnings call, participants should register online at the Fortrea Investor Relations website .
A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.

Founding Open Source Zone Members OIN, The Linux Foundation, and Microsoft Mark Five Years of Successes in Protecting Open Source Software from Patent Assertion Entities

Retrieved on:

Wednesday, April 10, 2024

Since their initial founding of the OS Zone in 2019, OIN, The Linux Foundation, and Microsoft have invested substantially to protect open-source software (OSS) from Patent Assertion Entities (PAEs) – sometimes referred to as patent trolls.

Key Points:

Since their initial founding of the OS Zone in 2019, OIN, The Linux Foundation, and Microsoft have invested substantially to protect open-source software (OSS) from Patent Assertion Entities (PAEs) – sometimes referred to as patent trolls.
Additional support for OS Zone funding comes from Amazon, Apple, CableLabs (Cable Companies Trade Organization), Mercedes-Benz, Meta, ServiceNow, and Twilio.
“As open source technology continues its inexorable growth into new markets, PAEs have increasingly targeted the OSS community,” said Keith Bergelt, CEO of Open Invention Network.
“We see significant value in partnering again with The Linux Foundation and Microsoft, to support the Unified Patents OS Zone.

CREO's Mike Townley Receives Triangle Business Journal's 2024 Life Sciences Award

Retrieved on:

Friday, April 26, 2024

Creo, Health, Growth, Entrepreneurship, TBJ, Completeness, American City Business Journals, Organization, Pharmaceutical industry

DURHAM, N.C., April 26, 2024 /PRNewswire-PRWeb/ -- CREO Inc., the preferred consultancy to the world's most promising companies that seek to improve human health, today announced that Mike Townley, President and Co-Founder, has been honored with the Triangle Business Journal's 2024 Life Sciences Award.

Key Points:

CREO Inc., the preferred consultancy to the world's most promising companies that seek to improve human health, today announced that Mike Townley, President and Co-Founder, has been honored with the Triangle Business Journal's 2024 Life Sciences Award.
DURHAM, N.C., April 26, 2024 /PRNewswire-PRWeb/ -- CREO Inc., the preferred consultancy to the world's most promising companies that seek to improve human health, today announced that Mike Townley, President and Co-Founder, has been honored with the Triangle Business Journal's 2024 Life Sciences Award.
This prestigious accolade recognizes Townley's contributions to the life sciences sector, highlighting his commitment to improving human health through innovative business strategies and leadership.
The Triangle Business Journal (TBJ) 2024 Life Sciences Award is an esteemed honor that celebrates outstanding leaders making noteworthy strides in the life sciences field.

Leyline Renewable Capital Provides Development Capital Facility for Interconnection Deposits to Belltown Power

Retrieved on:

Wednesday, April 24, 2024

MISO, Federal Energy Regulatory Commission, FERC, Renewable energy

DURHAM, N.C., April 24, 2024 /PRNewswire/ -- Leyline Renewable Capital, a leading provider of flexible capital solutions for renewable energy developers, today announced their second lending facility with Belltown Power, building on their success from previous transactions. Leyline's investment of MISO interconnection deposits will support Belltown's development of 800 MW of solar plus storage and standalone storage in the MISO market within the next three years.

Key Points:

DURHAM, N.C., April 24, 2024 /PRNewswire/ -- Leyline Renewable Capital , a leading provider of flexible capital solutions for renewable energy developers, today announced their second lending facility with Belltown Power, building on their success from previous transactions.
Leyline's investment of MISO interconnection deposits will support Belltown's development of 800 MW of solar plus storage and standalone storage in the MISO market within the next three years.
This rule aims to reduce premature or unfeasible interconnection requests, but also comes with higher upfront financial costs for interconnection studies and deposits.
Leyline fills that gap by providing non-dilutive financing, which allows Belltown to advance its projects through the MISO Interconnection queue while maintaining control of the company and growing its portfolio of projects.

Introducing Santander Pharma Consulting, An Experienced Partner in Commercial Strategy

Retrieved on:

Tuesday, April 23, 2024

Entrepreneurship, CFO, Growth, Pharmaceutical industry

DURHAM, N.C., April 23, 2024 /PRNewswire/ -- Today marks the official launch of Santander Pharma Consulting, a dynamic and innovative consulting firm with a commitment to excellence, integrity, and unparalleled expertise, Santander Pharma Consulting is set to become the go-to partner for pharmaceutical companies of all sizes seeking strategic guidance and operational support.

Key Points:

Santander Pharma Consulting officially launched, as an innovative commercial strategy consulting firm with a commitment to excellence, integrity, and unparalleled expertise.
Santander Pharma Consulting brings together a team of seasoned professionals with extensive experience across all facets of the pharmaceutical sector.
"At Santander Pharma Consulting, our mission is clear: to help our clients optimize their commercial success by leveraging our teams' experience"," said Robert Yanez, Co-Founder and CEO of Santander Pharma Consulting.
With a comprehensive suite of services, Santander Pharma Consulting offers commercial planning services designed to optimize every stage of the commercialization lifecycle.

Aramco Wins ISA100 Wireless Excellence in Automation Award

Retrieved on:

Friday, April 19, 2024

Wireless, Phillips 66, International Society, PETRONAS, ARC, Steam, WCI, Swift, BAPCO, Petrom, Acquisition, Plant, ISA, Mobile phone

DURHAM, N.C., April 19, 2024 /PRNewswire/ -- The International Society of Automation (ISA) – the leading professional society for automation – and the ISA100 Wireless Compliance Institute (WCI) have announced that Aramco, a global integrated energy and chemicals company, has won the 2023 ISA100 Wireless Excellence in Automation award for their novel application of wireless instrumentation at a key operating site, the Fadhili Gas Plant. Aramco is recognized this year for pioneering the large-scale deployment of an ISA100 Wireless steam trap monitoring solution. Aramco is joining a distinguished list of end users who have received this award over the past 11 years.

Key Points:

Annual award honors novel application of wireless instrumentation at Fadhili Gas Plant; learn more at 24 April webinar
DURHAM, N.C., April 19, 2024 /PRNewswire/ -- The International Society of Automation (ISA) – the leading professional society for automation – and the ISA100 Wireless Compliance Institute (WCI) have announced that Aramco, a global integrated energy and chemicals company, has won the 2023 ISA100 Wireless Excellence in Automation award for their novel application of wireless instrumentation at a key operating site, the Fadhili Gas Plant.
Each year, the ISA100 Wireless Compliance Institute presents the ISA100 Wireless Excellence in Automation Award to a global end user company that has demonstrated outstanding leadership and innovation with ISA100 Wireless technology.
Notable past end-user recipients of the ISA100 Wireless Excellence in Automation Award include OMV Petrom, Enquest UK, Fuji Oil Company, Ltd., ILBOC, BAPCO, Alcoa, Phillips 66, PETRONAS and Nippon Steele & Sumikin Engineering.
The deployed ISA100 Wireless network is based on a distributed topology centered on an ISA100 Wireless field gateway and multiple ISA100 Wireless field backbone routers.

James Scott Farrin Attorney Daniel Bello Elected to Board of Directors for Hispanic/Latino Legal Issues Committee

Retrieved on:

Thursday, April 18, 2024

Law, Justice

DURHAM, N.C., April 18, 2024 /PRNewswire/ -- Daniel Bello, a bilingual personal injury attorney at the Law Offices of James Scott Farrin, has been elected Secretary of the North Carolina Advocates for Justice (NCAJ) Hispanic/Latino Legal Issues Division. As Secretary, Daniel will help the NCAJ increase access to justice for Spanish-speaking people. Daniel is the latest James Scott Farrin attorney to serve the NCAJ and help further their mission – 49 of the firm's attorneys are NCAJ members.

Key Points:

North Carolina Advocates for Justice (NCAJ) elects Bello to the board for its Hispanic/Latino Legal Issues Division, which works to ensure equal access to justice.
DURHAM, N.C., April 18, 2024 /PRNewswire/ -- Daniel Bello , a bilingual personal injury attorney at the Law Offices of James Scott Farrin , has been elected Secretary of the North Carolina Advocates for Justice (NCAJ) Hispanic/Latino Legal Issues Division.
Daniel is the latest James Scott Farrin attorney to serve the NCAJ and help further their mission – 49 of the firm's attorneys are NCAJ members.
"It's an honor to be elected an officer of the board," says Bello.